GoAI
Get started
DocGo Inc. logo

DocGo Inc.

DCGO

NASDAQHealthcareMedical - Care Facilities

Open in GoAI

Previous close

$0.4345

+$0.0041 · +0.95%

Aug 21, 4:00 PM ET

Pre-market

$0.4399

+$0.0054 · +1.24%

Aug 24, 7:00 AM ET

DCGO company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

47

Fair Value

Momentum

30

Weakening

Sentiment

36

Bearish

Risk resilience

28

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

DocGo Inc. is a company dedicated to providing mobile healthcare solutions and medical transportation for a wide array of healthcare organizations in both the United States and the United Kingdom. Their transportation portfolio includes critical emergency response, alongside routine non-emergency transfers facilitated by ambulance and specialized wheelchair-accessible vehicles. Additionally, DocGo offers a range of mobile health services, delivered directly to patients' homes and offices through its advanced digital platform. These services further extend to include COVID-19 diagnostic testing and comprehensive on-site healthcare support for various events, such as large sporting competitions and concerts. The company was founded in 2015 and is headquartered in New York, New York.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
US
CEO
Lee Bienstock
Listed since
Dec 17, 2020
Employees
3,568

Market position

Day range

Current $0.4345

52-week range

Current $0.4345

Open
$0.4269
Previous close
$0.4304
Volume
558.69K
0.66× average
Average volume
850.83K
Average daily volume
Market cap
42.92M USD
Beta
0.99
Market reference 1
50-day average
$0.5896
-26.30% below average
200-day average
$0.7239
-39.97% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
65.12M USD
EV / EBITDA
-0.38×
Earnings yield
-209.74%
Free cash flow yield
31.07%

Profitability & efficiency

Return on equity
-126.66%
Return on assets
-84.02%
Return on invested capital
-55.78%

Financial health

Current ratio
2.26×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends44%8%-29%-66%Gross margin, FY2021: 34.43%Gross margin, FY2022: 35.12%Gross margin, FY2023: 31.30%Gross margin, FY2024: 34.64%Gross margin, FY2025: 30.65%Operating margin, FY2021: 4.82%Operating margin, FY2022: 4.96%Operating margin, FY2023: 2.41%Operating margin, FY2024: 4.65%Operating margin, FY2025: -27.67%Net margin, FY2021: 7.45%Net margin, FY2022: 7.85%Net margin, FY2023: 1.10%Net margin, FY2024: 3.24%Net margin, FY2025: -56.61%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 34.43%. Gross margin FY2022 35.12%. Gross margin FY2023 31.30%. Gross margin FY2024 34.64%. Gross margin FY2025 30.65%. Operating margin FY2021 4.82%. Operating margin FY2022 4.96%. Operating margin FY2023 2.41%. Operating margin FY2024 4.65%. Operating margin FY2025 -27.67%. Net margin FY2021 7.45%. Net margin FY2022 7.85%. Net margin FY2023 1.10%. Net margin FY2024 3.24%. Net margin FY2025 -56.61%.

Income trends

Revenue

322.2M USD-47.74%

Operating income

−89.16M USD−117.85M USD

Net income

−182.4M USD−202.39M USD
Income trends across reported periods704.96M USD382.28M USD59.61M USD−263.07M USDRevenue, FY2021: 318.72M USDRevenue, FY2022: 440.52M USDRevenue, FY2023: 624.29M USDRevenue, FY2024: 616.56M USDRevenue, FY2025: 322.2M USDOperating income, FY2021: 15.36M USDOperating income, FY2022: 21.83M USDOperating income, FY2023: 15.05M USDOperating income, FY2024: 28.69M USDOperating income, FY2025: −89.16M USDNet income, FY2021: 23.74M USDNet income, FY2022: 34.58M USDNet income, FY2023: 6.86M USDNet income, FY2024: 19.99M USDNet income, FY2025: −182.4M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 318.72M USD. Revenue FY2022 440.52M USD. Revenue FY2023 624.29M USD. Revenue FY2024 616.56M USD. Revenue FY2025 322.2M USD. Operating income FY2021 15.36M USD. Operating income FY2022 21.83M USD. Operating income FY2023 15.05M USD. Operating income FY2024 28.69M USD. Operating income FY2025 −89.16M USD. Net income FY2021 23.74M USD. Net income FY2022 34.58M USD. Net income FY2023 6.86M USD. Net income FY2024 19.99M USD. Net income FY2025 −182.4M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue322.2M USD616.56M USD624.29M USD440.52M USD318.72M USD
Cost of goods sold223.44M USD402.98M USD428.91M USD285.79M USD208.97M USD
Gross profit98.76M USD213.57M USD195.38M USD154.72M USD109.75M USD
Research and development13.56M USD11.59M USD10.86M USD5.38M USD3.32M USD
Selling, general, and administrative158.69M USD157.41M USD153.04M USD116.94M USD83.56M USD
Operating expenses187.91M USD184.89M USD180.33M USD132.89M USD94.39M USD
Interest income—236.95K USD1.68M USD762.69K USD—
Interest expense1.01M USD2.17M USD——763.03K USD
Depreciation and amortization15.66M USD15.88M USD16.43M USD10.57M USD7.51M USD
Operating income−89.16M USD28.69M USD15.05M USD21.83M USD15.36M USD
Net income−182.4M USD19.99M USD6.86M USD34.58M USD23.74M USD

Company facts updated Aug 24, 2026.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Rating distribution

8 ratings
Strong buy00%
Buy788%
Hold113%
Sell00%
Strong sell00%

DCGO peers

Amgen Inc. logo

AMGN

Amgen Inc.

$439.33

+1.29%

Gilead Sciences, Inc. logo

GILD

Gilead Sciences, Inc.

$146.12

+1.87%

Vertex Pharmaceuticals Incorporated logo

VRTX

Vertex Pharmaceuticals Incorporated

$548.05

+1.44%

Intuitive Surgical, Inc. logo

ISRG

Intuitive Surgical, Inc.

$378.81

+1.16%

Sanofi logo

SNY

Sanofi

$45.85

+1.55%

Regeneron Pharmaceuticals, Inc. logo

REGN

Regeneron Pharmaceuticals, Inc.

$834.04

+0.90%

ETFs holding DCGO

Funds reporting this stock among their holdings, ordered by reported position size.

Vanguard Morningstar Total Stock Market ETF logoVanguard Morningstar Total Stock Market ETFVTI
Market value
1.73M
Weight
0.00%
AUM
2.3T USD
Expense ratio
0.03%
Price / 1D
$378.24+0.44%
Vanguard Extended Market ETF logoVanguard Extended Market ETFVXF
Market value
625.49K
Weight
0.00%
AUM
93.7B USD
Expense ratio
0.05%
Price / 1D
$245.53+0.82%
Schwab U.S. Small-Cap ETF logoSchwab U.S. Small-Cap ETFSCHA
Market value
188.02K
Weight
0.00%
AUM
23.1B USD
Expense ratio
0.03%
Price / 1D
$34.83+0.52%
Vanguard Health Care ETF logoVanguard Health Care ETFVHT
Market value
170.65K
Weight
0.00%
AUM
20.9B USD
Expense ratio
0.09%
Price / 1D
$327.7+1.24%
EA Bridgeway Omni Small-Cap Value ETF logoEA Bridgeway Omni Small-Cap Value ETFBSVO
Market value
50K
Weight
—
AUM
1.71B USD
Expense ratio
0.47%
Price / 1D
$29.62+0.85%
Invesco RAFI US 1500 Small-Mid ETF logoInvesco RAFI US 1500 Small-Mid ETFPRFZ
Market value
45.96K
Weight
0.00%
AUM
2.87B USD
Expense ratio
0.34%
Price / 1D
$55.89+0.87%

Continue in GoAI

Research DCGO

research.disclaimer